SCHEMBL7110774

SCHEMBL7110774

CCSc1nc(Cl)nc2nc[nH]c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.51
MAP3K5 Q99683 1/20 0.44
PAK1 Q13153 1/20 0.43
POLB P06746 1/20 0.43
PIN1 Q13526 1/20 0.43
TMIGD3 P0DMS9 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
ALDH1A1 P00352 1/20 0.42
TOP2A P11388 1/20 0.42
HPGD P15428 1/20 0.42
NUDT1 P36639 1/20 0.42
HIF1A Q16665 1/20 0.42
CDC7 O00311 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16758710 0.81 MAP3K5 (0.69) MAP3K5POLBPIN1HSD17B10CYP1A2
SCHEMBL25402245 0.78 POLB (0.71) POLBPIN1TMIGD3HTR2CHTR2B
SCHEMBL31439407 0.75 PAK1 (0.71) PAK1HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL2115555 0.75 PAK1 (0.71) PAK1HSD17B10CYP1A2CYP3A4CYP2D6
SCHEMBL16146535 0.75 XDH (0.56) XDHMAP3K5TMIGD3HTR2CHTR2B
Alcohol SCHEMBL27897029 0.73 DPP4 (0.54) XDHTMIGD3HTR2CHTR2BCDK1
SCHEMBL4451634 0.72 XDH (0.61) XDHTMIGD3HTR2CHTR2BDPP4
SCHEMBL24500763 0.72 XDH (0.56) XDHTMIGD3HTR2CHTR2BCDK2
SCHEMBL1443987 0.71 PDPK1 (0.56) XDHPIN1TMIGD3HTR2CHTR2B
SCHEMBL5839305 0.71 XDH (0.51) XDHTMIGD3HTR2CHTR2BDPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200435-B1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK NOVARTIS AG (CH) 2003-10-01 EP disclosed
US-6589950-B1 Treatment of inflammatory or obstructive airways disease for respiratory system disorders NOVARTIS AG (CH) 2003-07-08 US disclosed
EP-1200435-A1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK Novartis AG (CH) 2002-05-02 EP disclosed
WO-2001009134-A1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK NOVARTIS AG (CH) 2001-02-08 WO disclosed